Diagnostic and Prognostic Accuracy of Gold Nanoparticles in Salivary Gland Tumours

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

August 6, 2018

Primary Completion Date

February 3, 2019

Study Completion Date

February 3, 2021

Conditions
Carcinoma Ex Pleomorphic Adenoma of Salivary GlandsPleomorphic Adenoma of Salivary Glands
Interventions
DIAGNOSTIC_TEST

CD24-Gold Nanocomposite expression using Real-time quantitative polymerase chain reaction

new strategy where gold nanoparticles synthetized and added to CD24 primer forming CD24-Gold Nanocomposite to be used for detection of cancer stem cells

DIAGNOSTIC_TEST

non-conjugated CD24 expression using Real-time quantitative polymerase chain reaction

conventional strategy using non-conjugated CD24 expression to used for detection of cancer stem cells

Trial Locations (1)

12511

Faculty of Dentistry, October 6 University, Giza

All Listed Sponsors
lead

Amina Fouad Farag

OTHER

NCT04907422 - Diagnostic and Prognostic Accuracy of Gold Nanoparticles in Salivary Gland Tumours | Biotech Hunter | Biotech Hunter